CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PFIZER

PFE
$159.99BLarge Cap

Next catalyst

Phase 3Q4 2026

Rimegepant

Acute Migraine

Get an email about PFE's next catalysts

Track PFIZER (PFE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 47 more upcoming events in our data (Phase 2 readout, Phase 3 readout, trial start).See the timeline

Catalyst Timeline

48 upcoming, 5 past

Phase 3Next

Rimegepant Phase 3 Est. Readout

Q4 2026~QRimegepant723

Primary completion for Rimegepant trial (NCT06641466) in Menstrual Migraine

Source
Phase 2

elranatamab Phase 2 Est. Readout

December 2026~elranatamab30

Estimated primary completion for elranatamab trial (NCT06832865) in Relapsed Refractory Multiple Myeloma (RRMM). Topline data typically follows completion by weeks to months.

Source
Phase 3

Ritlecitinib higher dose Phase 3 Est. Readout (B7981027)

December 2026~Ritlecitinib higher dose208

Primary completion for Ritlecitinib higher dose trial (NCT07029828) in Severe Alopecia Areata

Source
Phase 2

Sunitinib Phase 2 Est. Readout

December 2026~Sunitinib50

Estimated primary completion for Sunitinib trial (NCT03297606) in Lymphoma, Non-Hodgkin. Topline data typically follows completion by weeks to months.

Source
Phase 3

VLA15 Phase 3 Est. Readout

December 2026~VLA151,712

Primary completion for VLA15 trial (NCT07500506) in Lyme Disease

Source
Phase 2

Ritlecitinib Phase 2 Est. Readout

December 2026~Ritlecitinib128

Primary completion for Ritlecitinib trial (NCT07228390) in Hidradenitis Suppurativa

Source
Phase 2

disitamab vedotin Phase 2 Est. Readout

December 2026~disitamab vedotin372

Primary completion for disitamab vedotin trial (NCT04879329) in Urothelial Carcinoma

Source
Phase 2

Tucatinib Oral Tablet Phase 2 Est. Readout (ETIC-LM)

December 2026~Tucatinib Oral Tablet30

Estimated primary completion for Tucatinib Oral Tablet trial (NCT05800275) in Leptomeningeal Metastasis. Topline data typically follows completion by weeks to months.

Source

How PFE's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsPharmaceutical🇺🇸North AmericaNEW YORK75.0K employees

Pfizer Inc. (/ˈfaɪzər/ FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.

Website
Drug Pipeline

Epoetin Hospira

Phase 3

Chronic Renal Failure Requiring Hemodialysis

Remicade

Phase 3

Crohn's Disease

Enbrel (etanercept)

Phase 3

Ankylosing Spondylitis

Zmax

Phase 3

Otitis Media

Venlafaxine ER

Phase 3

Panic Disorder

Levonorgestrel and Ethinyl Estradiol

Phase 3

Oral Contraceptive

ARV-471

Phase 3

Advanced Breast Cancer

ARV-471 (PF-07850327)

Phase 3

Breast Cancer

heptavalent pneumococcal conjugate vaccine, Prevenar

Phase 3

Allogeneic Haematopoietic Stem Cell Transplantation

valdecoxib

Phase 3

Pain

Havrix (HAV)

Phase 3

Meningococcal Vaccine

NWP09

Phase 3

Attention Deficit Hyperactivity Disorder

PF-07220060

Phase 3

Liposarcoma

Diflucan IV, oral

Phase 3

Candidiasis

Rimegepant (PF-07899801)

Phase 3

Acute Treatment of Migraine

13 valent Pneumococcal Conjugate Vaccine

Phase 3

Pneumococcal Infections

7vPnc pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

Bifeprunox

Phase 3

Schizophrenia

CT-P13

Phase 3

Crohn's Disease

Sunitinib malate

Phase 3

Breast Neoplasms

Ethambutol hydrochloride

Phase 3

Mycobacterium Avium-intracellulare Infection

ritonavir

Phase 3

COVID-19

ReFacto AF

Phase 3

Hemophilia A

binimetinib

Phase 3

MSS

ropinirole

Phase 3

Parkinson Disease

Desvenlafaxine Succinate Sustained-Release

Phase 3

Major Depressive Disorder

Ceftazidime - Avibactam (CAZ-AVI)

Phase 3

Complicated Urinary Tract Infection

Etanercept

Phase 3

Pulmonary Fibrosis

Avelumab (MSB0010718C)

Phase 3

Renal Cell Cancer

Steroids

Phase 3

Kidney Failure

rFIX

Phase 3

Hemophilia B

In open-label phase: treatment with tofacitinib

Phase 3

Arthritis Juvenile Idiopathic

Ibuprofen ER

Phase 3

Pain

cefuroxime plus erythromycin

Phase 3

Pneumonia

PF-05280014

Phase 3

Metastatic Breast Cancer

Quillivant Oral Suspension XR

Phase 3

Attention Deficit Hyperactivity Disorder

Prevenar 13™

Phase 3

Infections, Meningococcal

Desvenlafaxine Succinate

Phase 3

Major Depressive Disorder

Enzalutamide

Phase 3

Breast Cancer

Voriconazole

Phase 3

Neutropenia

indobufen

Phase 3

Atrial Fibrillation

desvenlafaxine

Phase 3

Depressive Disorder, Major

Isovorin

Phase 3

Gastric Cancer

Nirmatrelvir

Phase 3

COVID-19

Doripenem

Phase 3

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Midazolam

Phase 3

Sedation

Artemether-lumefantrine

Phase 3

Malaria, Falciparum

Crizotinib

Phase 3

Non Small Cell Lung Cancer

Rapamune

Phase 3

Renal Allograft Recipients

Effexor XR

Phase 3

Depression

Fesoterodine PR

Phase 3

Urinary Bladder, Neurogenic

desipramine

Phase 3

Depression

procarbazine hydrochloride

Phase 3

Brain and Central Nervous System Tumors

desvenlafaxine succinate sustained release

Phase 3

Vasomotor Symptoms

Anidulafungin, VER002

Phase 3

Aspergillosis

treatment

Phase 3

Non Squamous Lung Cancer

Tofacitinib

Phase 3

Rheumatoid Arthritis

Etrasimod

Phase 3

Alopecia Areata

Elranatamab

Phase 3

Multiple Myeloma

Fenofibrate

Phase 3

Hyperlipidemia

Disease-modifying antirheumatic drug

Phase 3

Arthritis, Rheumatoid

20vPnC

Phase 3

Pneumococcal Disease

Genotonorm

Phase 3

Growth Disorders

Varenicline tartrate

Phase 3

Smoking Cessation

pegaptanib sodium

Phase 3

Macular Degeneration

rLP2086 vaccine

Phase 3

Meningitis, Meningococcal

Apixaban

Phase 3

Atrial Fibrillation

Talazoparib

Phase 3

Prostate Cancer

Fx-1006A

Phase 3

Familial Amyloid Polyneuropathy

Sulfadoxine-Pyrimethamine/Chloroquine

Phase 3

PLASMODIUM FALCIPARUM MALARIA

Mefloquine

Phase 3

Malaria, Falciparum

CP 690,550

Phase 3

Rheumatoid Arthritis

PN-152,243)/PN-196,444

Phase 3

Sarcoma

Physician's-Choice

Phase 3

Breast Neoplasms

Bazedoxifene Acetate

Phase 3

Osteoporosis

gemcitabine hydrochloride

Phase 3

Lung Cancer

Sigvotatug Vedotin

Phase 3

Non-Small Cell Lung Cancer

Epogen Amgen

Phase 3

Chronic Renal Failure

desvenlafaxine SR

Phase 3

Depression

PVC (daily, 7 days off)

Phase 3

Atrophic Vaginitis

Dexmedetomidine HCL Injection

Phase 3

Awake Fiberoptic Intubation

Bazedoxifene/Conjugated Estrogen

Phase 3

Vaginal Atrophy

desvenlafaxine succinate sustained release tablets

Phase 3

Major Depressive Disorder

Cyclosporine

Phase 3

Kidney Transplant

Amphotericin B

Phase 3

Mycoses

Pegvisomant

Phase 3

Acromegaly

Ceftaroline

Phase 3

Community-Acquired Bacterial Pneumonia

MenACWY-TT

Phase 3

Meningococcal ACWY Disease

PF-06741086

Phase 3

Hemophilia A

Clostridium difficile vaccine

Phase 3

Clostridium Difficile Associated Disease

DVS-SR

Phase 3

Major Depressive Disorder

Varenicline

Phase 3

Smoking

RSVpreF Vaccine

Phase 3

Respiratory Syncytial Virus

Enfortumab Vedotin

Phase 3

Urothelial Cancer

Levofloxacin

Phase 3

Community-Acquired Infections

daunorubicin + cytarabine

Phase 3

Leukemia, Myeloid, Acute

Dimebon

Phase 3

Alzheimer's Disease

PF-06801591

Phase 3

Advanced Malignancies

Desvenlafaxine Sustained Release

Phase 3

Fibromyalgia

Bacillus Calmette-Guerin

Phase 3

Non-muscle Invasive Bladder Cancer

IBU BID

Phase 3

Pain

PF-07248144

Phase 3

Breast Cancer

gemtuzumab ozogamicin

Phase 3

Leukemia

PF-06838435/fidanacogene elaparvovec

Phase 3

Hemophilia B

13vPnC + TIV

Phase 3

Pneumococcal Infections

CP-690,550 (tofacitinib)

Phase 3

Juvenile Idiopathic Arthritis

PF-02341066

Phase 3

Carcinoma, Non-Small-Cell Lung

Antibiotic

Phase 3

Pneumonia, Pneumococcal

Sunitinib + Capecitabine

Phase 3

Breast Neoplasms

Axitinib (AG-013736)

Phase 3

Hepatocellular Carcinoma

Osivelotor

Phase 3

Sickle Cell Disease

Azithromycin plus Chloroquine

Phase 3

Malaria

Tiotropium low dose QD

Phase 3

Asthma

DIC075V (intravenous diclofenac sodium)

Phase 3

Pain, Postoperative

PhXA41

Phase 3

Glaucoma

Interferon Alfa

Phase 3

Carcinoma, Renal Cell

13-valent Pneumoccocal Conjugate Vaccine

Phase 3

Pneumococcal Conjugate Vaccine

PF-08634404

Phase 3

Carcinoma, Hepatocellular

azithromycin (Zithromax)

Phase 3

Pneumonia

Group Hydroxychloroquine

Phase 3

Complication

Group Apixaban

Phase 3

Complication

Trastuzumab + Pertuzumab

Phase 3

HER2 Positive Breast Cancer

Temsirolimus (CCI-779)

Phase 3

Advanced Renal Cell Carcinoma

Tiotropium Respimat

Phase 3

Asthma

Glasdegib

Phase 3

Acute Myeloid Leukemia

chemotherapy

Phase 3

Leukemia

IV Iron

Phase 3

Chronic Kidney Disease (CKD)

fluoxetine

Phase 3

Major Depressive Disorder

olmesartan alone or in combination with hydrochlorothiazide

Phase 3

Essential Hypertension

MERREM I.V. as a 3 hour infusion every 8 hours

Phase 3

Pneumonia

PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy

Phase 3

Hemophilia A

Ertapenem

Phase 3

Bacterial Infections

Inclacumab

Phase 3

Sickle Cell Disease

Amoxicillin/clavulinic acid

Phase 3

Bronchitis, Chronic

cefuroxime

Phase 3

Pneumonia

Ertugliflozin

Phase 3

Diabetes Mellitus, Type 2

Dazukibart

Phase 3

Dermatomyositis

azithromycin sustained release

Phase 3

Pneumonia

Azithromycin/Chloroquine

Phase 3

Malaria, Falciparum

Tiotropium high dose QD

Phase 3

Asthma

Mevrometostat

Phase 3

Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Bapineuzumab 1.0 m/kg

Phase 3

Alzheimer's Disease

tiotropium Respimat high dose

Phase 3

Asthma

folic acid, vitamin B12 (cyanocobalamin)

Phase 3

Coronary Artery Disease

Group Hydroxychloroquine and apixaban

Phase 3

Complication

tiotropium Respimat low dose

Phase 3

Asthma

vitamin B6 (pyridoxine)

Phase 3

Coronary Artery Disease

Crisaborole Ointment

Phase 3

Atopic Dermatitis

Vanquix Auto-Injector (Diazepam Injection)

Phase 3

Seizures

Dexmedetomidine hydrochloride

Phase 3

Sedation

somatropin - GH treated cohort

Phase 3

Prader-Willi Syndrome

Rimegepant/BHV3000

Phase 3

Pediatric Migraine

PF-06438179

Phase 3

Rheumatoid Arthritis

Fentanyl

Phase 3

Anesthesia

Irinotecan + 5 FU + folinic acid

Phase 3

Colorectal Neoplasms

NSAID

Phase 3

Chronic Pain

Ritlecitinib lower dose

Phase 3

Severe Alopecia Areata

Epogen (Amgen)

Phase 3

Chronic Kidney Disease

PPSV23

Phase 3

Pneumococcal Disease

"Investigational"Auto-injector (sumatriptan succinate)

Phase 3

Migraine

VLA15

Phase 3

Lyme Borreliosis

Bococizumab (PF-04950615; RN316)

Phase 3

Hyperlipidemia

23-valent Pneumococcal Polysaccharide Vaccine

Phase 3

Pneumococcal Vaccines

BeneFIX

Phase 3

Hemophilia B

Background NSAID

Phase 3

Spondylitis, Ankylosing

VFEND® I.V., Oral

Phase 3

Candidiasis

DVS SR

Phase 3

Depressive Disorder, Major

PF-06821497

Phase 3

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Ribociclib

Phase 3

Breast Cancer

CP-945,598

Phase 3

Obesity

cabergoline

Phase 3

Restless Legs Syndrome

voriconazole (Vfend)

Phase 3

Candidiasis

Ceftriaxone sodium

Phase 3

Intra-abdominal Infections

Bazedoxifene Acetate (TSE-424)

Phase 3

Osteoporosis

Ibuprofen caplet

Phase 3

Patient Compliance

Bococizumab

Phase 3

Hyperlipidemia

Crisaborole

Phase 3

Atopic Dermatitis

somatropin - adult cohort

Phase 3

Prader-Willi Syndrome

Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR)

Phase 3

Depression

Topical IBU three times daily

Phase 3

Ankle Injuries

PF-08046054

Phase 3

Non-small Cell Carcinoma

CP-690, 550

Phase 3

Psoriasis

CAZ-AVI

Phase 3

Complicated Intra-Abdominal Infection

Berobenatide

Phase 3

Apnea

Cold-adapted influenza vaccine trivalent (CAIV-T)

Phase 3

Influenza

Milnacipran

Phase 3

Depression

naproxen

Phase 3

Osteoarthritis

Fentanyl/Morphine

Phase 3

Sedation

Ibuprofen

Phase 3

Post-surgical Pain Following Extraction of Molar Teeth

Temsirolimus

Phase 3

Renal Cell Carcinoma

Etoposide + cisplatin

Phase 3

Small Cell Lung Carcinoma

20-valent pneumococcal conjugate vaccine (20vPnC)

Phase 3

Pneumococcal Disease

Unfractionated Heparin (UFH)

Phase 3

Deep Vein Thrombosis

tolterodine tartrate

Phase 3

Overactive Bladder

Following the planned interim analysis for this study: Avelumab

Phase 3

Urothelial Cancer

bazedoxifene BZA-20

Phase 3

Postmenopause

rimegepant ODT

Phase 3

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Rapamune®

Phase 3

Kidney Disease

Pertuzumab

Phase 3

HER2 Positive Breast Cancer

Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine

Phase 3

Alopecia Areata

23-valent Pneumococcal Polysaccharide Vaccine (23vPS)

Phase 3

HIV Infections

Anidulafungin

Phase 3

Neutropenia

adenosine

Phase 3

Coronary Artery Disease

Varenicline Tartarate

Phase 3

Smoking Cessation

Placebp

Phase 3

Respiratory Syncytial Virus

Treatment with Genotropin in different dosages

Phase 3

Growth Disorder

prinomastat

Phase 3

Brain and Central Nervous System Tumors

MEK162

Phase 3

Metastatic Colorectal Cancer

Abrocitinib

Phase 3

Atopic Dermatitis

5 fluorouracil

Phase 3

Metastatic Colorectal Cancer

LGX818

Phase 3

Solid Tumors Harboring a BRAF V600 Mutation

vemurafenib

Phase 3

Melanoma

Genotonorm (Somatropin)

Phase 3

Fetal Growth Retardation

Xyntha

Phase 3

Hemophilia A

Zavegepant (BHV-3500)

Phase 3

Acute Migraine

RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE

Phase 3

Respiratory Syncytial Virus (RSV)

SU011248

Phase 3

Gastrointestinal Stromal Tumors

Seasonal Inactivated Influenza Vaccine

Phase 3

Respiratory Syncytial Virus

IV Diclofenac

Phase 3

Postoperative Pain

Piperacillin/Tazobactam (Tazocin)

Phase 3

Hematologic Neoplasms

effervescent ibuprofen tablets

Phase 3

Pain

CP690,550

Phase 3

Ulcerative Colitis

FOLFIRI regimen

Phase 3

Colorectal Cancer

clarithromycin extended release (ER)

Phase 3

Pneumonia

Xiapex

Phase 3

Dupuytren's Contracture

MTZ

Phase 3

Complicated Intra-abdominal Infection

vaccine-13vPnC

Phase 3

Pneumococcal Infections

PF-04965842

Phase 3

Atopic Dermatitis

ATM-AVI

Phase 3

Complicated Intra-Abdominal Infections, cIAIs

Recombinant Coagulation Factor IX (BeneFIX)

Phase 3

Hemophilia B

Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Phase 3

Encephalitis, Tick-Borne

Xalacom

Phase 3

Glaucoma, Open-Angle

Topical IBU twice daily

Phase 3

Ankle Injuries

PLD

Phase 3

Ovarian Cancer

Lorlatinib

Phase 3

Carcinoma, Non-Small-Cell Lung

Ibuprofen Immediate Release/Extended Release Caplet

Phase 3

Analgesia

Clostridium difficile

Phase 3

Clostridium Difficile Associated Disease

PD 0332334

Phase 3

Generalized Anxiety Disorder

Taxotere®

Phase 3

Early Breast Cancer

PD-0332991

Phase 3

Neoplasms

UFT

Phase 3

Colon Cancer

PF-07275315 dose 1

Phase 3

Moderate to Severe Chronic Obstructive Pulmonary Disease

PF-08653944

Phase 3

Obesity

Leuprolide Open Label

Phase 3

Hormone Sensitive Prostate Cancer

MabThera®

Phase 3

Follicular Lymphoma

MenACWY-CRM

Phase 3

Meningococcal Vaccine

DA-9501

Phase 3

Sedation

rLP2086

Phase 3

Healthy

Investigational Medical Product (IMP) administered in parent study

Phase 3

Osteoarthritis

VENLAFAXINE

Phase 3

Panic Disorders

PF-05280586

Phase 3

Rheumatoid Arthritis

PG4

Phase 3

Pneumococcal Disease

CE/MPA

Phase 3

Endometrial Hyperplasia

Quadrivalent influenza modRNA vaccine

Phase 3

Influenza, Human

voxelotor

Phase 3

Sickle Cell Disease

Standard Ibuprofen

Phase 3

Pain

23vPS

Phase 3

Vaccines, Pneumococcal Conjugate Vaccine

Zyvox®/Linezolid

Phase 3

Bacterial Infections

Megestrol acetate

Phase 3

Metastatic Breast Cancer

Fragmin/Dalteparin Sodium

Phase 3

Diabetic Foot Ulcer

Rimegepant Orally Disintegrating Tablets (ODT)

Phase 3

Acute Migraine

Lorazepam

Phase 3

Reflex Epilepsy, Photosensitive

RSVpreF MDV

Phase 3

Respiratory Syncytial Virus (RSV)

TBE vaccine

Phase 3

Tick-Borne Encephalitis

Exubera (inhaled insulin)

Phase 3

Diabetes Mellitus, Type 2

Plant cell expressed recombinant glucocerebrosidase (prGCD)

Phase 3

Gaucher Disease

ibuzatrelvir

Phase 3

COVID-19 Infection

Inotuzumab ozogamicin

Phase 3

ACUTE LYMPHOBLASTIC LEUKEMIA

PF-00299804

Phase 3

Carcinoma, Non Small Cell Lung

7vPnC

Phase 3

Vaccines, Pneumococcal

FLAG (fludarabine, cytarabine and G-CSF)

Phase 3

Acute Lymphoblastic Leukemia

MenABCWY

Phase 3

Meningococcal Vaccine

PF-06462700

Phase 3

Aplastic Anemia

Multivalent Group B streptococcus vaccine

Phase 3

Group B Streptococcus Infections

Infanrix hexa

Phase 3

Healthy

PF-06651600 Induction Dose

Phase 3

Alopecia Areata

Either switch to oral therapy: of Ciprofloxacin (oral)

Phase 3

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

C.difficile vaccine

Phase 3

Clostridioides Difficile Associated Disease

Celebrex

Phase 3

Osteoarthritis,Knee

Abemaciclib

Phase 3

Breast Cancer

or switch to oral therapy:/of sulfamethoxazole/trimethoprim (oral)

Phase 3

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

propiverine

Phase 3

Urinary Bladder, Overactive

CAIV-T

Phase 3

Influenza

ATRA plus 6-MP and MTX

Phase 3

Leukemia, Myelocytic, Acute

Sirolimus (Rapamune®)

Phase 3

Renal Transplant

somatrogon

Phase 3

Growth Hormone Deficiency

ampicillin sodium/sulbactam sodium

Phase 3

Pneumonia, Bacterial

(PN-152,243)/PN-196,444

Phase 3

Neoplasms

Chemotherapy Regimen 1

Phase 3

Advanced Non-Small Cell Lung Cancer

ALO-02

Phase 3

Chronic Pain

exemestane (Aromasin)

Phase 3

Breast Neoplasms

somatropin - GH naïve pediatric cohort

Phase 3

Prader-Willi Syndrome

Sirolimus (RAPAMUNE)

Phase 3

Graft vs Host Disease

Irinotecan hydrochloride trihydrate

Phase 3

Esophageal Cancer

Meningococcal group C polysaccharide conjugate vaccine

Phase 3

Neisseria Meningitidis

pantoprazole for approximately 9 weeks

Phase 3

Gastroesophageal Reflux

Methotrexate - Immediate

Phase 3

Rheumatoid Arthritis

Moxifloxacin

Phase 3

Chronic Bronchitis

binodenoson

Phase 3

Coronary Artery Disease

Itraconazole

Phase 3

Antifungal Prophylaxis of Invasive Fungal Infections

bivalent rLP2086

Phase 3

Meningococcal Infection

Inhaled human insulin

Phase 3

Diabetes Mellitus, Type 1

relugolix, estradiol, norethindrone acetate

Phase 3

Endometriosis

Pneumo23/Pneumovax

Phase 3

Rheumatoid Arthritis

Hib

Phase 3

Pneumococcal Infections

FDC IBU/APAP

Phase 3

Pain

Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)

Phase 3

Pneumococcal Disease

Elotuzumab

Phase 3

Multiple Myeloma

TS-1

Phase 3

Gastric Cancer

Axitinib plus Toripalimab

Phase 3

Renal Cell Carcinoma

Avelumab

Phase 3

Urothelial Cancer

FSME-IMMUN NEW

Phase 3

Tick-borne Encephalitis

Methotrexate - Delay

Phase 3

Rheumatoid Arthritis

rFIX-R

Phase 3

Hemophilia B

Sunitinib

Phase 3

Lymphoma, Non-Hodgkin

levoleucovorin

Phase 3

Colorectal Neoplasms

Bleomycin

Phase 3

Hodgkin Lymphoma

tiotropium Respimat® high dose

Phase 3

Asthma

HZ/su VACCINE

Phase 3

Respiratory Syncytial Virus (RSV)

leucovorin

Phase 3

Colorectal Carcinoma

Vinblastine

Phase 3

Hodgkin Lymphoma

PMI-150 (intranasal ketamine)

Phase 3

Pain, Postoperative

tiotropium Respimat® low dose

Phase 3

Asthma

CCI-779

Phase 3

Multiple Sclerosis, Relapsing-Remitting

Interferon Alfa and CCI-779

Phase 3

Carcinoma, Renal Cell

Aromatase Inhibitors

Phase 3

Metastatic Breast Cancer

Maraviroc (UK-427,857)

Phase 3

HIV Infections

amoxicillin/clavulanate postassium (Augmentin ES-600)

Phase 3

Acute Otitis Media

Advanced therapy only without dietary intervention

Phase 3

Ulcerative Colitis

Haematopoietic growth factor

Phase 3

Hodgkin Lymphoma

Chemotherapy Regimen 2

Phase 3

Carcinoma

Fulvestrant Injectable Product

Phase 3

Metastatic Breast Cancer

Optimized Background Therapy

Phase 3

HIV Infections

azithromycin SR

Phase 3

Acute Otitis Media

Dicloxacillin

Phase 3

Bacterial Infections

Oxacillin

Phase 3

Bacterial Infections

Ibuprofen/acetaminophen

Phase 3

Pain

Donepezil (Aricept)

Phase 3

Alzheimer Disease

Lorlatanib

Phase 3

Advanced Malignancies

Utomilumab

Phase 3

Stage III Breast Cancer

PF-06651600 Maintenance Dose #3

Phase 3

Alopecia Areata

Standard-of-Care plus Dexmedetomidine

Phase 3

Endotracheal Intubation

RSVpreF (Group 2)

Phase 3

RSV

diphtheria, tetanus, and acellular pertussis vaccine (DTaP)

Phase 3

Healthy Subjects

PF-06651600 Maintenance Dose #1

Phase 3

Alopecia Areata

RSVpreF (Group 3)

Phase 3

RSV

SABER-Bupivacaine

Phase 3

Postoperative Pain

PF04965842

Phase 3

Atopic Dermatitis

recombinant human growth hormone

Phase 3

Abdominal Obesity

PF-06651600 Maintenance Dose #2

Phase 3

Alopecia Areata

CMP 001

Phase 3

Advanced Malignancies

PF04518600

Phase 3

Advanced Malignancies

BNT162b2

Phase 3

SARS-CoV-2 Infection

brentuximab vedotin

Phase 3

Lymphoma, B-Cell

Ketamine

Phase 3

Chronic Daily Headache

DVS-233 SR (desvenlafaxine sustained release)

Phase 3

Major Depressive Disorder

Insulin Lispro

Phase 3

Diabetes Mellitus

Cyclosporine A

Phase 3

Renal Transplantation

13 valent pneumococcal conjugate vaccine with Polysorbate 80

Phase 3

Vaccines, Pneumococcal

Meropenem

Phase 3

Complicated Intra-abdominal Infections

MET097

Phase 3

Obesity

RSVpreF (Group 1)

Phase 3

RSV

Imipenem-cilastatin

Phase 3

Skin Infection

Diclofenac

Phase 3

Spondylitis, Ankylosing

Pediacel

Phase 3

Vaccines, Pneumococcal

Pemetrexed/Cisplatin

Phase 3

NSCLC (Non-small Cell Lung Cancer)

Conventional amphotericin B

Phase 3

Candidiasis

bazedoxifene/conjugated estrogens

Phase 3

Menopause

azithromycin SR (Zithromax; compound: CP-62,993)

Phase 3

Maxillary Sinusitis

desvenlafaxine succinate (DVS) SR

Phase 3

Vasomotor Symptoms

PF-06823859

Phase 3

Myositis

axitinib

Phase 3

Carcinoma, Non-Small Cell Lung

Ritlecitinib

Phase 3

Stable Nonsegmental Vitiligo

Nonacog alfa

Phase 3

Hemophilia B

Novel Ibuprofen

Phase 3

Pain

AG-013736

Phase 3

Carcinoma, Pancreatic Ductal

Epoetin Hospira Arm

Phase 3

Chronic Kidney Disease (CKD)

Imipenem

Phase 3

Bacterial Pneumonia

marstacimab

Phase 3

Hemophilia A

Bosutinib

Phase 3

Polycystic Kidney, Autosomal Dominant

Inhaled Insulin

Phase 3

Asthma

Rimegepant

Phase 3

Acute Migraine

Bazedoxifene/Conjugate Estrogens (CE)

Phase 3

Endometrial Hyperplasia

7-valent Pneumococcal Conjugate Vaccine

Phase 3

Pneumococcal Infection

Modified Bolus 5-FU/LV with Irinotecan

Phase 3

Colorectal Neoplasms

varenicline (CP-526,555)

Phase 3

Smoking Cessation

Tigecycline

Phase 3

Gram-Positive Bacterial Infections

fesoterodine fumarate

Phase 3

Overactive Bladder

SPM 907

Phase 3

Overactive Bladder Syndrome

Somatropin

Phase 3

Endocrine System Diseases

Parecoxib Sodium/Valdecoxib

Phase 3

Pain

Palbociclib

Phase 3

Breast Cancer

DVS-233

Phase 3

Menopause

Tisotumab Vedotin

Phase 3

Cervical Cancer

13-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Vaccines

AN2690 Topical

Phase 3

Onychomycosis of Toenails

AN2728 Topical

Phase 3

Dermatitis, Atopic

levonorgestrel/ethinyl estradiol

Phase 3

Menstruation Disturbances

Ritlecitinib higher dose

Phase 3

Severe Alopecia Areata

PF-07321332

Phase 3

COVID-19

Pentavac

Phase 3

Vaccines, Pneumococcal

Encorafenib

Phase 3

BRAF V600E-mutant Metastatic Colorectal Cancer

20-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Disease

Talazoparib with enzalutamide

Phase 3

mCRPC

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)

Phase 3

Meningitis, Meningococcal

Genotropin

Phase 3

Idiopathic Short Stature

bapineuzumab

Phase 3

Alzheimer Disease

DTaP-IPV-HBV/Hib combination vaccine, Infanrix hexa

Phase 3

Allogeneic Haematopoietic Stem Cell Transplantation

Zavegepant

Phase 3

Migraine

[S,S]-Reboxetine

Phase 3

Fibromyalgia

PF-06651600

Phase 3

Active Non-segmental Vitiligo

Taliglucerase alfa

Phase 3

Gaucher Disease

PF-06410293

Phase 3

Rheumatoid Arthritis

linezolid

Phase 3

Febrile Neutropenia

Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)

Phase 3

Neisseria Meningitidis (Bacterial Meningitis)

Desvenlafaxine succinate sustained-release (DVS SR)

Phase 3

Depression

Epirubicin with Cyclophosphamide, followed by a Taxane

Phase 3

Adenocarcinoma

Ceftazidime-avibactam

Phase 3

Complicated Intra-abdominal Infection

talazoparib plus enzalutamide

Phase 3

Prostate Cancer

Ibuprofen/Caffeine

Phase 3

Pain

PF-06947386

Phase 3

Complicated Intra-abdominal Infection

tucatinib

Phase 3

HER2-positive Breast Cancer

CP-690,550

Phase 3

Crohn's Disease

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Phase 3

Encephalitis, Tick-borne

Bococizumab (PF-04950615;RN316)

Phase 3

Hyperlipidemia

ponsegromab

Phase 3

Non-small Cell Lung Cancer

Dexmedetomidine

Phase 3

Sedation

DVS-233 SR

Phase 3

Major Depressive Disorder

Dacomitinib (PF-00299804)

Phase 3

Non-Small Cell Lung Cancer

Genotropin (PN-180,307) Somatropin

Phase 3

Infant, Small for Gestational Age

sumanirole

Phase 3

Parkinson Disease

UK-390,957

Phase 3

Ejaculation

torcetrapib/atorvastatin

Phase 3

Hyperlipidemia

dalteparin

Phase 3

Venous Thromboembolism

RSVpreF

Phase 3

RSV Infection

disitamab vedotin

Phase 3

Urothelial Carcinoma

Fesoterodine

Phase 3

Overactive Bladder Syndrome

Nimenrix

Phase 3

Meningococcal Vaccine

7-Valent Pneumococcal Conjugate Vaccine (7vPnC)

Phase 3

Healthy Subjects

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

13-valent pneumococcal conjugate vaccine (13vPnC)

Phase 3

Healthy Subjects

Moroctocog alfa (AF-CC)

Phase 3

Hemophilia A

lecozotan SR (SRA-333)

Phase 3

Alzheimer Disease

7 valent pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

Inhaled human insulin (EXUBERA™)

Phase 3

Diabetes Mellitus, Type 2

Tolterodine ER

Phase 3

Overactive Bladder

Fragmin

Phase 3

Diabetic Foot Ulcer

Tafamidis

Phase 3

Transthyretin (TTR) Amyloid Cardiomyopathy

Interferon-alfa

Phase 3

Carcinoma, Renal Cell

tanezumab

Phase 3

Arthritis

13vPnC

Phase 3

Vaccines, Pneumococcal Conjugate Vaccine

Rifabutin

Phase 3

Mycoses

endocrine-modulating drug therapy

Phase 3

Prostate Cancer

Ibuprofen Sodium

Phase 3

Pain

ceftazidim-avibactam (CAZ-AVI, experimental product)

Phase 3

Nosocomial Pneumonia (NP)

leflunomide

Phase 3

Prostate Cancer

Cyclosporin or tacrolimus

Phase 3

Graft Rejection

Edotecarin

Phase 3

Breast Neoplasms

Ceftaroline fosamil

Phase 3

Complicated Skin and Soft Tissue Infection

Sasanlimab

Phase 2

Urothelial Carcinoma Bladder

DTP/Hib

Phase 2

Meningitis, Meningococcal

NMDA Antagonist, CP-101,606 (traxoprodil)

Phase 2

Depressive Disorder, Major

MultiStem high dose

Phase 2

Colitis, Ulcerative

maraviroc (Selzentry)

Phase 2

HIV Infections

Vaccine Candidate #1

Phase 2

Healthy Adults

AN2898

Phase 2

Dermatitis, Atopic

PF-08653945

Phase 2

Overweight

Dorzolamide

Phase 2

Glaucoma

PF-08049820

Phase 2

Atopic Dermatitis

PF-06826647

Phase 2

Psoriasis

Allegra

Phase 2

Allergic Rhinitis

Letrozole/Temsirolimus (CCI-779)

Phase 2

Breast Neoplasms

AG-013726

Phase 2

Colorectal Neoplasms

EXC 001 (currently called PF-06473871)

Phase 2

Reduction in Severity of Skin Scarring

Carfilzomib, proteasome inhibitor; intravenous

Phase 2

Advanced Multiple Myeloma

PF-06835919

Phase 2

Non-alcoholic Steatohepatitis

PF-07850327, ARV-471, vepdegestrant

Phase 2

Locally Advanced or Metastatic ER+ HER2- Breast Cancer

CP-690-550

Phase 2

Arthritis, Rheumatoid

SU-011,248

Phase 2

Kidney Neoplasms

Sunitinib (SU011248)

Phase 2

Liver Neoplasms

Tygacil

Phase 2

Bacterial Infections

tacedinaline

Phase 2

Pancreatic Cancer

Multivalent Pneumococcal Vaccine - Formulation 1

Phase 2

Pneumococcal Disease

SU011248, Sutent

Phase 2

Papillary Thyroid Cancer

Multivalent Pneumococcal Vaccine - Formulation 2

Phase 2

Pneumococcal Disease

PF-04217329 - Lowest Dose

Phase 2

Primary Open-Angle Glaucoma

(Part C) MET097

Phase 2

Obesity and Overweight

inotuzumab ozogamicin (CMC-544)

Phase 2

Lymphoma, B-Cell

PF-07104091 monotherapy dose escalation

Phase 2

Small Cell Lung Cancer

NR2B NMDA Antagonist CP-101,606 (traxoprodil)

Phase 2

Parkinson's Disease

Capecitabine tablets

Phase 2

Leptomeningeal Metastasis

PF-06291874

Phase 2

Diabetes Mellitus, Type II

Bupivacaine TTS (Bupivacaine Patch)

Phase 2

Chronic Low Back Pain

MRE0094

Phase 2

Foot Ulcer, Diabetic

(CP-690,550) Tofacitinib

Phase 2

Plaque Psoriasis

PF-03654746

Phase 2

Excessive Daytime Sleepiness

PF-06882961

Phase 2

Diabetes

PF-00489791

Phase 2

Diabetic Nephropathies

PF-00217830

Phase 2

Schizophrenia

UK-453, 061

Phase 2

HIV-1

EKB-569

Phase 2

Colorectal Neoplasms

Multivalent Pneumococcal Vaccine - Formulation 3

Phase 2

Pneumococcal Disease

ARRY-502, CRTh2 antagonist; oral

Phase 2

Asthma

Levonorgestrel

Phase 2

Ovulation

Formulation A

Phase 2

Respiratory Tract Infections

Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection

Phase 2

Shingles

CPG 7909 Injection

Phase 2

Carcinoma, Melanoma

Low dose cytarabine

Phase 2

Acute Myeloid Leukemia

Multivalent Pneumococcal Vaccine - Formulation 4

Phase 2

Pneumococcal Disease

Phase Ib ARRY-614 + nivolumab+ipilimumab

Phase 2

Renal Cell Carcinoma

Multivalent

Phase 2

Pneumococcal Infections

Filibuvir

Phase 2

Hepatitis

CP-690,550 + methotrexate

Phase 2

Rheumatoid Arthritis

Samuraciclib

Phase 2

Breast Cancer

AN2728

Phase 2

Psoriasis

PF-06823859 low

Phase 2

Dermatomyositis

PF-04494700 (TTP488)

Phase 2

Diabetic Nephropathy

QS-21

Phase 2

Alzheimer Disease

Selenomethionine (SLM)

Phase 2

Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)

PF-04937319

Phase 2

Type 2 Diabetes Mellitus

BGJ398

Phase 2

Melanoma

ARRY-438162, MEK inhibitor; oral

Phase 2

Rheumatoid Arthritis

ACC-001

Phase 2

Alzheimer's Disease

FOLFIRI (The combination regimen of Irinotecan, l-Leucovorin and 5-Fluorouracil)

Phase 2

Unresectable or Metastatic Colorectal Cancer

PF-05089771

Phase 2

Postoperative Dental Pain

SKI-606 (Bosutinib)

Phase 2

Chronic Myelogenous Leukemia

PF-00610355

Phase 2

Pulmonary Disease, Chronic Obstructive

PF-04217329 - High Dose

Phase 2

Primary Open-Angle Glaucoma

PBO

Phase 2

Hypercholesterolemia

PF-299804 (Dacomitinib)

Phase 2

Glioblastoma

PF-04136309

Phase 2

Osteoarthritis, Knee

vepdegestrant

Phase 2

Breast Cancer

PF-04236921

Phase 2

Crohn's Disease

Pentostatin

Phase 2

Chronic Lymphocytic Leukemia

Meningococcal C

Phase 2

Meningitis, Meningococcal

PD 0348292

Phase 2

Venous Thrombosis

PF-06835919 Low Dose

Phase 2

Non-alcoholic Fatty Liver Disease

Axitinib Oral Tablet

Phase 2

Renal Cell Carcinoma

PF-04457845

Phase 2

Osteoarthritis, Knee

BAT

Phase 2

Gram-negative Bacterial Infections

Anrukinzumab

Phase 2

Colitis, Ulcerative

PH-797804

Phase 2

Pulmonary Disease, Chronic Obstructive

UK-369,003

Phase 2

Prostatic Hyperplasia

Tucatinib in Combination of Oral VP16 and trastuzumab

Phase 2

HER2-positive Breast Cancer

Phase II ARRY-614 + nivolumab+ipilimumab (melanoma)

Phase 2

Renal Cell Carcinoma

Taxotere (docetaxel)

Phase 2

Prostatic Neoplasms

PF-07868489

Phase 2

Pulmonary Arterial Hypertension

Nicotine Adaptive Protocol

Phase 2

Nicotine Dependence

High Dose PF-07328948

Phase 2

Heart Failure

exemestane (Aromasin®)

Phase 2

Breast Neoplasms

SS-RBX

Phase 2

Urinary Incontinence, Stress

PF-06650833

Phase 2

Acne Inversa

Bosutinib (Phase 2 part)

Phase 2

Amyotrophic Lateral Sclerosis

PF - 00610355

Phase 2

Pulmonary Disease, Chronic Obstructive

Tucatinib (ONT-380)

Phase 2

Metastatic Breast Cancer ( HER2 Negative)

Elranatamab (PF-06863135)

Phase 2

Multiple Myeloma

PF-00734200

Phase 2

Diabetes Mellitus, Type 2

Anti-Beta Interferon (PF-06823859)

Phase 2

Dermatomyositis

mPnC candidate

Phase 2

Healthy Participants

PF-07220060 + PF-07104091 combination dose escalation

Phase 2

Breast Cancer

EXC 001

Phase 2

Scar Prevention

SAM-531

Phase 2

Alzheimer Disease

Trastuzumab plus Pertuzumab

Phase 2

Lymphoma, Non-Hodgkin

mIRV

Phase 2

Influenza, Human

PF- 00610355

Phase 2

Pulmonary Disease, Chronic Obstructive

Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor inhibitor

Phase 2

Kidney Neoplasms

CP-778,875

Phase 2

Dyslipidemia

Atomoxetine

Phase 2

Attention Deficit Disorder With Hyperactivity

CP-533, 536

Phase 2

Tibial Fractures

SBI-087

Phase 2

Active Rheumatoid Arthritis

Methotrexate plus ERB-041

Phase 2

Rheumatoid Arthritis

PF-04494700 - Low Dose Arm

Phase 2

Alzheimer Disease

RN624 (PF-04383119)

Phase 2

Osteoarthritis

Elranatamab + Nirogacestat

Phase 2

Multiple Myeloma

rhBMP-2/CPM

Phase 2

Fractures

ACC-001 + QS21

Phase 2

Alzheimer Disease

CE-224,535

Phase 2

Arthritis, Rheumatoid

BNT162b2 (Omi XBB.1.5)/RIV

Phase 2

Influenza, Human

Hormone therapy

Phase 2

Metastatic Breast Cancer With a Isolated Brain Progression

MultiStem low dose

Phase 2

Colitis, Ulcerative

Doxil

Phase 2

Breast Cancer

Doxorubicin Hydrochloride

Phase 2

Hodgkin Lymphoma

Sitexsentin sodium

Phase 2

Diastolic Heart Failure

SPK-9001

Phase 2

Hemophilia B

CP-866,087

Phase 2

Alcoholism

Tucatinib Oral Tablet

Phase 2

Leptomeningeal Metastasis

AG013736

Phase 2

Thyroid Neoplasms

PF-07275315

Phase 2

Asthma

ARRY-371797, p38 inhibitor; oral

Phase 2

LMNA-Related Dilated Cardiomyopathy

Phase II ARRY-614 + nivolumab

Phase 2

Renal Cell Carcinoma

CP-751,871

Phase 2

Prostatic Neoplasms

CPG10101

Phase 2

Hepatitis, Chronic Active

PF-06372865

Phase 2

Chronic Low Back Pain

CMC-544 (Inotuzumab Ozogamycin)

Phase 2

Acute Lymphoblastic Leukemia

RSV Vaccine

Phase 2

Respiratory Tract Infection

Elrantamab

Phase 2

Multiple Myeloma

PF-04383119 (tanezumab)

Phase 2

Osteoarthritis, Knee

Investigational drug

Phase 2

Carcinoma, Non-Small-Cell Lung

SU011248 capsule

Phase 2

Carcinoma, Renal Cell

interferon beta treatment to add-on atorvastatin treatment

Phase 2

Relapsing Remitting Multiple Sclerosis

Dacomitinib

Phase 2

Non-small Cell Lung Cancer

PF-00232798

Phase 2

HIV

SB-525 (PF-07055480)

Phase 2

Hemophilia A

PF-07817883

Phase 2

SARS-CoV-2 Infection

Belinostat

Phase 2

Metastatic Uveal Melanoma

Medium Dose PF-07328948

Phase 2

Heart Failure

PF06700841

Phase 2

Active Non-segmental Vitiligo

ILV-094

Phase 2

Rheumatoid Arthritis

pneumococcal polysaccharide and protein conjugate vaccines

Phase 2

Pneumococcal Infections

Crizotinib (PF-02341066)

Phase 2

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma

Paclitaxel,Gemcitabine,Sunitinib

Phase 2

Breast Cancer

Low Dose PF-07328948

Phase 2

Heart Failure

SU011248 (sunitinib)

Phase 2

Carcinoma, Renal Cell Metastasis

Linezolid (TIW)

Phase 2

Tuberculosis, Multidrug-Resistant

Rapamune® (Sirolimus)

Phase 2

Kidney Transplantation

SD-6010

Phase 2

Osteoarthritis

CP-690,550 Ointment 1

Phase 2

Psoriasis

AN2690

Phase 2

Onychomycosis

Gardasil

Phase 2

Vaccines

Sertraline and Elzasonan Combination

Phase 2

Depressive Disorder, Major

Ponezumab

Phase 2

Cerebral Amyloid Angiopathy

PF-00868554

Phase 2

Hepatitis C

maplirpacept (PF-07901801)

Phase 2

Diffuse Large B-Cell Lymphoma

Vaccine

Phase 2

Meningococcal Vaccine

bIRV AA

Phase 2

Influenza, Human

Licensed pediatric hepatits A vaccine

Phase 2

MENINGOCOCCAL INFECTION

SU014813

Phase 2

Breast Neoplasms

Tdap

Phase 2

Pneumococcal Infections

rLP2086 + MCV4 + Tdap

Phase 2

Vaccines

Temsirolimus and Sorafenib

Phase 2

Thyroid Cancer

Ceftazidime -avibactam

Phase 2

Complicated Urinary Tract Infections

Atovaquone

Phase 2

Bacterial Infections

(CP-6890,550) Tofacitinib

Phase 2

Plaque Psoriasis

CP-547,632

Phase 2

Ovarian Neoplasms

Esreboxetine

Phase 2

Fibromyalgia

UK-453,061

Phase 2

HIV-1

PF-06473871

Phase 2

Reduction of Hypertrophic Skin Scarring

15-valent pneumococcal conjugate vaccine (PCV15)

Phase 2

Pneumococcal Disease

untreated to atorvastatin treatment

Phase 2

Relapsing Remitting Multiple Sclerosis

Sulfamethoxazole-Trimethoprim

Phase 2

Bacterial Infections

RIV

Phase 2

Influenza, Human

rLP2086 and Gardasil

Phase 2

Vaccines

Sunitinib Malate Continuous Daily Dosing

Phase 2

Carcinoma, Renal Cell

PF-00446687

Phase 2

Erectile Dysfunction

NXL104/ceftazidime

Phase 2

Complicated Urinary Tract Infection

Duavee

Phase 2

Breast Cancer

ERB-041

Phase 2

Endometriosis

bIRV AB

Phase 2

Influenza, Human

AG-013736 (Axitinib)

Phase 2

Acute Myeloid Leukemia (AML)

temsirolimus plus liposomal doxorubicin

Phase 2

Sarcoma

LEE011

Phase 2

Locally Advanced or Metastatic NRAS Mutant Melanoma

Macugen ™ (pegaptanib sodium injection)

Phase 2

Macular Degeneration

7-valent pneumococcal conjugate vaccine (vaccine)

Phase 2

HIV Infections

PF-07976016

Phase 2

Obesity

qIRV

Phase 2

Influenza, Human

PF-04494700

Phase 2

Alzheimer's Disease

CP-751, 871

Phase 2

Colorectal Neoplasm

PF-610,355

Phase 2

Asthma

CP-690,550 Eye drops

Phase 2

Dry Eye Syndromes

CP-690,550 Ointment 2

Phase 2

Psoriasis

Tofimilast

Phase 2

Asthma

Tiotropium bromide

Phase 2

Asthma

Tick-borne Encephalitis Vaccine

Phase 2

Tick-borne Encephalitis

PF-02545920

Phase 2

Huntington's Disease

Sumatriptan

Phase 2

Migraine

bIRV BB

Phase 2

Influenza, Human

PF-04991532

Phase 2

Diabetes Mellitus, Type 2

ceftazidime/NXL104 + metronidazole

Phase 2

Complicated Intra-abdominal Infections

INC280

Phase 2

Melanoma

MAC-321

Phase 2

Colorectal Neoplasms

Combination [RSVpreF+BNTb162b2]

Phase 2

Healthy Participants

PD-0299685

Phase 2

Hot Flashes

tiotropium-bromide

Phase 2

Asthma

Dexmedetomidine, midazolam; fentanyl

Phase 2

Intubated and Mechanically Ventilated Pediatric Subjects

CP- 690 550

Phase 2

Ulcerative Colitis

PF-04191834

Phase 2

Asthma

PF-04171327

Phase 2

Rheumatoid Arthritis

Gemtuzumab Ozogamicin (GO)

Phase 2

Acute Myeloid Leukemia

23-valent pneumococcal conjugate vaccine (vaccine)

Phase 2

HIV Infections

Anti-NGF AB

Phase 2

Neoplasms

Mylotarg (gemtuzumab ozogamicin) Injection

Phase 2

Acute Myelogenous Leukemia

ACC-001 (vanutide cridificar)

Phase 2

Alzheimer's Disease

PD 0299685

Phase 2

Interstitial Cystitis

Elranatamab injection

Phase 2

Refractory Multiple Myeloma

PF-06882961 (Cohorts 1 and 2)

Phase 2

Obesity

Bazedoxifene

Phase 2

Postmenopausal Osteoporosis

PF-05221304

Phase 2

Nonalcoholic Fatty Liver Disease

ARRY-520, KSP(Eg5) inhibitor; intravenous

Phase 2

Multiple Myeloma

ALO-01

Phase 2

Healthy

FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU])

Phase 2

Colorectal Neoplasms

Capravirine

Phase 2

Human Immunodeficiency Virus

Bivalent rLP2086 Vaccine

Phase 2

MENINGOCOCCAL INFECTION

Prevenar13

Phase 2

IgG Deficiency

TMI-005

Phase 2

Rheumatoid Arthritis

Combination 1

Phase 2

Carcinoma, Renal Cell

BNT162b2 (Omi XBB.1.5)

Phase 2

Influenza, Human

Influenza ModRNA Vaccine

Phase 2

Influenza, Human

ATM-AVI Single Dose, Cohorts 1-4

Phase 2

Gram-negative Bacterial Infection

Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)

Phase 2

Group B Streptococcal Infections

Investigational Influenza Vaccine

Phase 2

Influenza

meningococcal B rLP2086 vaccine

Phase 2

Meningitis, Meningococcal

Anti-OX40 Antibody PF-04518600

Phase 2

Stage III Breast Cancer

FUFA

Phase 2

Colorectal Cancer

PF-04217329 - Low Dose

Phase 2

Primary Open-Angle Glaucoma

PF-04217329 - High Middle Dose

Phase 2

Primary Open-Angle Glaucoma

PF-07264660

Phase 2

Atopic Dermatitis

PF-3512676

Phase 2

Lymphoma, T-Cell, Cutaneous

PF-00592379

Phase 2

Impotence

sulopenem and PF-03709270

Phase 2

Pneumonia, Bacterial

PF-4217329 - Highest Dose

Phase 2

Primary Open-Angle Glaucoma

PF-07038124 ointment

Phase 2

Atopic Dermatitis

Rapamycin

Phase 2

Nonmalignant Neoplasm

WNT974

Phase 2

Metastatic Colorectal Cancer

sunitinib malate dose escalation

Phase 2

Gastrointestinal Stromal Tumors

Tetanus, diphtheria, and acellular pertussis vaccine

Phase 2

Group B Streptococcus Infections

PF-04447943

Phase 2

Alzheimer's Disease

PD 0332991

Phase 2

Breast Cancer

PF-06835375

Phase 2

Primary Immune Thrombocytopenia

Torisel

Phase 2

Adenocarcinoma

meningococcal B rLP2086 vaccine candidate

Phase 2

Meningitis, Meningococcal

Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab

Phase 2

Lung Cancer (NSCLC)

ARRY-334543, EGFR/ErbB2 inhibitor; oral

Phase 2

Advanced Cancer

Recombinant Human Interleukin-11 (rhIL-11)

Phase 2

Crohn Disease

sitaxsentan (Thelin)

Phase 2

Cardiac Surgery Subjects

Bosutinib (Phase 1 part)

Phase 2

Amyotrophic Lateral Sclerosis

C. difficile vaccine (previously studied formulation)

Phase 2

Clostridoides Difficile Associated Disease

PF-07038124

Phase 2

Atopic Dermatitis

Kaletra

Phase 2

HIV Infections

PF-05221304 Monotherapy

Phase 2

Non-Alcoholic Fatty Liver Disease (NAFLD)

Alclometasone cream

Phase 2

Non Small Cell Lung Cancer (NSCLC)

852A

Phase 2

Melanoma

PD 0200390

Phase 2

Nonrestorative Sleep

PF-03654764

Phase 2

Allergic Rhinitis

PD0332991

Phase 2

Breast Neoplasms

MET233 and MET097

Phase 2

Obesity and Obesity-related Medical Conditions

Vemurafenib plus Cobimetinib

Phase 2

Lymphoma, Non-Hodgkin

vabicaserin

Phase 2

Schizophrenia

CI-1033

Phase 2

Breast Neoplasms

CE-326,597

Phase 2

Weight Management

PF00299804

Phase 2

Advanced Gastric Cancer

Repevax

Phase 2

Meningococcal Vaccine

CI 1033

Phase 2

Lung Neoplasms

PF-04383119

Phase 2

Cystitis, Interstitial

Open

Phase 2

Chronic Kidney Disease

Guaifenesin

Phase 2

Chronic Rhinitis

PF-06838435 (formerly SPK-9001)

Phase 2

Hemophilia B

RN624

Phase 2

Neuralgia, Postherpetic

PD-217,014

Phase 2

Irritable Bowel Syndrome

HSP-130

Phase 2

Non-metastatic Breast Cancer

Axitinib [AG-013736]

Phase 2

Melanoma

IMA-638

Phase 2

Asthma

PF-03446962

Phase 2

Malignant Pleural Mesothelioma

CP-526,555 (varenicline)

Phase 2

Smoking Cessation

Tolterodine & Pregabalin

Phase 2

Overactive Bladder

MET233

Phase 2

Obesity and Overweight

SCA-136

Phase 2

Schizophrenia

ACC-001/QS-21

Phase 2

Alzheimer's Disease

Tisotumab vedotin (HuMax-TF-ADC)

Phase 2

Ovary Cancer

Tamsulosin

Phase 2

Prostatic Hyperplasia

PF-06835919 High Dose

Phase 2

Non-alcoholic Fatty Liver Disease

Creatine

Phase 2

Amyotrophic Lateral Sclerosis

IMA-638 is a biologic

Phase 2

Asthma

CPG 7909

Phase 2

Carcinoma, Non-Small Cell Lung

Vupanorsen

Phase 2

Dyslipidemias

Staphylococcus aureus 4-antigen vaccine

Phase 2

Staphylococcal Infections

SGN-35

Phase 2

CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma

Herceptin®

Phase 2

Carcinoma, Metastatic Breast

PF-07220060 CDK4 inhibitor

Phase 2

Advanced or Metastatic Breast Cancer

Peg-Intron

Phase 2

Hepatitis C

PF-06700841

Phase 2

Psoriatic Arthritis

Filanesib, KSP (Eg5) inhibitor; intravenous

Phase 2

Advanced Multiple Myeloma

Pediatric HAV vaccine

Phase 2

Meningococcal B Disease

Gemcitabine, nucleoside analogue; intravenous

Phase 2

Advanced Cancer

RV521

Phase 2

Respiratory Syncytial Virus Infections

Naproxen + PH-797804

Phase 2

Osteoarthritis

Irinotecan plus capecitabine

Phase 2

Carcinoma, Hepatocellular

Tasocitinib plus Methotrexate

Phase 2

Rheumatoid Arthritis

FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU])

Phase 2

Colorectal Neoplasms

PF-04236921 SC injection

Phase 2

Crohn's Disease

PF-04634817

Phase 2

Diabetic Nephropathy

Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)

Phase 2

Depression

ACC-001 + QS-21

Phase 2

Alzheimer Disease

cytarabine

Phase 2

Acute Myeloid Leukemia

ARRY-371797, p38 inhibitor, oral

Phase 2

LMNA-Related Dilated Cardiomyopathy

PELITREXOL/AG-2037

Phase 2

Colorectal Neoplasms

Phase Ib ARRY-614 + nivolumab

Phase 2

Renal Cell Carcinoma

Combination Agent 1

Phase 2

Advanced/Metastatic Non-Small Cell Lung Cancer

Phase II ARRY-614 + nivolumab+ipilimumab (RCC)

Phase 2

Renal Cell Carcinoma

UK0369,003

Phase 2

Impotence

PF-04449913

Phase 2

Acute Myeloid Leukemia

PF-04217329

Phase 2

Glaucoma, Open-Angle

Statin

Phase 2

Hypercholesterolemia

lecozotan SR

Phase 2

Alzheimer Disease

Tucatinib in Combination with Palbociclib and Letrozole

Phase 2

Breast Cancer

BYL719

Phase 2

Colorectal Cancer

MYO-029

Phase 2

Becker Muscular Dystrophy

Temodar and Irinotecan

Phase 2

Glioblastoma

MET097 Injection

Phase 2

Obesity in Diabetes

SRA-333

Phase 2

Alzheimer's Disease

CI-1040

Phase 2

Colorectal Neoplasms

Varenicline Adaptive Protocol

Phase 2

Nicotine Dependence

PF-04950615 (RN316)

Phase 2

Hypercholesterolemia

PF-04360365

Phase 2

Alzheimer's Disease

PF-06463922

Phase 2

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC

Sunitinib malate (SU011248)

Phase 2

Gastrointestinal Stromal Tumors

Gefitinib + Sunitinib

Phase 2

Carcinoma, Renal Cell

Pertuzumab/Trastuzumab

Phase 2

Metastatic Breast Cancer With a Isolated Brain Progression

PF-04383119 (RN624)

Phase 2

Low Back Pain

PF-06865571

Phase 2

Nonalcoholic Steatohepatitis

PF-04217329 - Middle Dose

Phase 2

Primary Open-Angle Glaucoma

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in PFIZER's drug pipeline?→

CatalystAlert tracks 810 drug candidates in PFIZER's (PFE) pipeline across Phase 3, Phase 2. Its lead program is Ritlecitinib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is PFIZER's next FDA catalyst?→

PFIZER's (PFE) next tracked catalyst is a Phase 3 readout expected Q4 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track PFE biotech catalysts?→

Add PFE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PFIZER's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply